Company research
Electromed, Inc.
CIK 1488917Updated Sep 27, 2026
SecurityELMD · NYSE_AMERICAN · equity
ELMD price & chart
Loading TradingView…
AMEX:ELMD on TradingView ↗About the company
Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.
In the news
No coverage from other publishers is available.
Recent filings
Results of Operations and Financial Condition · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 2.02, 5.02, 7.01, 9.01
10-K filing
144 filing
SD filing
4 filing
Show 5 more recent filings
144 filing
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
Financials
FY 2026 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 66,267,000Source | 53,802,000Source | 52,234,000Source | 45,806,000Source |
| Property, Plant and Equipment, NetUSD | 5,214,000Source | 4,714,000Source | 5,165,000Source | 5,672,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 20,450,000Source | 15,287,000Source | 16,080,000Source | 7,372,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 29,805,000Source | 24,660,000Source | 23,333,000Source | 24,130,000Source |
| Inventory, NetUSD | 3,681,000Source | 3,299,000Source | 3,712,000Source | 4,221,000Source |
| Assets, CurrentUSD | 57,368,000Source | 45,082,000Source | 44,173,000Source | 37,787,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,170,000Source | 392,000Source | 329,000Source | 1,577,000Source |
| Operating Lease, Right-of-Use AssetUSD | 131,000Source | 198,000Source | — | — |
| Other Assets, NoncurrentUSD | 1,270,000Source | 1,173,000Source | 87,000Source | 161,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 12,288,000Source | 10,593,000Source | 7,689,000Source | 8,139,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 84,000Source | 83,000Source | 87,000Source | 86,000Source |
| Additional Paid in CapitalUSD | 25,331,000Source | 21,941,000Source | 20,790,000Source | 18,788,000Source |
| Retained Earnings (Accumulated Deficit)USD | 28,564,000Source | 21,185,000Source | 23,668,000Source | 18,793,000Source |
| Stockholders' Equity Attributable to ParentUSD | 53,979,000Source | 43,209,000Source | 44,545,000Source | 37,667,000Source |
| Liabilities and EquityUSD | 66,267,000Source | 53,802,000Source | 52,234,000Source | 45,806,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 12,222,000Source | 10,468,000Source | 7,677,000Source | 8,053,000Source |
| Accounts Payable, CurrentUSD | 2,643,000Source | 2,667,000Source | 1,010,000Source | 1,372,000Source |
| Other Liabilities, NoncurrentUSD | 66,000Source | 125,000Source | — | — |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | — | 708,000Source | 651,000Source | 640,000Source |
cash flow · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 2,722,000Source | 3,059,000Source | 1,692,000Source | 708,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 5,145,000Source | 1,327,000Source | -797,000Source | 3,078,000Source |
| Increase (Decrease) in InventoriesUSD | 517,000Source | -175,000Source | -459,000Source | 1,033,000Source |
| Deferred Income Tax Expense (Benefit)USD | 426,000Source | -310,000Source | -571,000Source | -43,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 9,665,000Source | 11,393,000Source | 9,067,000Source | 1,315,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -1,300,000Source | -306,000Source | -395,000Source | -1,716,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,252,000Source | 262,000Source | 287,000Source | 1,648,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 249,000Source | 2,278,000Source | — | 310,000Source |
| Payments for Repurchase of Common StockUSD | 3,918,000Source | 10,000,000Source | 275,000Source | 153,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -3,202,000Source | -11,880,000Source | 36,000Source | -380,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 5,163,000Source | -793,000Source | 8,708,000Source | -781,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Income Taxes Paid, NetUSD | 3,393,000Source | — | — | -310,000Source |
| Additional Financial Items | ||||
| AmortizationUSD | 208,000Source | — | -52,000Source | -63,000Source |
| Share-based Payment Arrangement, ExpenseUSD | 2,722,000Source | 3,059,000Source | — | — |
| Amortization of Intangible AssetsUSD | 58,000Source | 133,000Source | 52,000Source | 63,000Source |
| DepreciationUSD | 868,000Source | 1,039,000Source | 789,000Source | 550,000Source |
| Impairment of Intangible Assets, Finite-livedUSD | 0Source | 212,000Source | — | — |
| Income Tax Expense (Benefit)USD | 3,059,000Source | 2,747,000Source | 1,886,000Source | 920,000Source |
| Net Income (Loss) Attributable to ParentUSD | 11,301,000Source | 7,537,000Source | 5,150,000Source | 3,166,000Source |
| Operating ExpensesUSD | 44,062,000Source | 40,311,000Source | 35,145,000Source | 32,511,000Source |
| Proceeds from Stock Options ExercisedUSD | 965,000Source | 398,000Source | — | — |
income statement · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total RevenueUSD | 73,776,000Source | 64,000,000Source | 54,716,000Source | 48,067,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 42,748,000Source | 39,315,000Source | 34,489,000Source | 31,595,000Source |
| Operating Income (Loss)USD | 13,881,000Source | 9,660,000Source | 6,581,000Source | 4,008,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 14,360,000Source | 10,284,000Source | 7,036,000Source | 4,086,000Source |
| Income Tax Expense (Benefit)USD | 3,059,000Source | 2,747,000Source | 1,886,000Source | 920,000Source |
| Net Income (Loss) Attributable to ParentUSD | 11,301,000Source | 7,537,000Source | 5,150,000Source | 3,166,000Source |
| Earnings Per Share, BasicUSD per share | 1.37Source | 0.89Source | 0.6Source | 0.37Source |
| Earnings Per Share, DilutedUSD per share | 1.3Source | 0.85Source | 0.58Source | 0.36Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 8,266,071Source | 8,454,100Source | 8,562,245Source | 8,463,684Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 8,688,563Source | 8,914,421Source | 8,864,585Source | 8,700,833Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 58,000Source | 133,000Source | 52,000Source | 63,000Source |
| Current Income Tax Expense (Benefit)USD | 2,633,000Source | 3,057,000Source | 2,457,000Source | 963,000Source |
| Gross ProfitUSD | 57,943,000Source | 49,971,000Source | 41,726,000Source | 36,519,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 14,360,000Source | — | — | — |
| Interest Income (Expense), NetUSD | — | — | 455,000Source | 78,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | 479,000Source | 624,000Source | — | — |
| Marketing and Advertising ExpenseUSD | 1,680,000Source | 1,421,000Source | 1,487,000Source | 1,244,000Source |
| Operating ExpensesUSD | 44,062,000Source | 40,311,000Source | 35,145,000Source | 32,511,000Source |
| Research and Development ExpenseUSD | 1,314,000Source | 996,000Source | 656,000Source | 916,000Source |
Filing attachments
elmd250097_ex99-1.htm · 8-K · 2025-02-11
EX-99.1 2 elmd250097_ex99-1.htm ELECTROMED, INC. ANNOUNCES RECORD FINANCIAL PERFORMANCE IN FISCAL 2025 SECOND QUARTER Exhibit 99.1 Electromed, Inc. Announces Record Financial Performance in Fiscal 2025 Second Quarter Company maintained strong momentum to deliver another quarter of record revenue and earnings, while continuing to invest in multiple strategic growth initiatives NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a lea…
Read attachment ↗elmd250097_ex99-2.htm · 8-K · 2025-02-11
EX-99.2 3 elmd250097_ex99-2.htm | 1 INVESTOR PRESENTATION ELECTROMED, INC. INVESTOR PRESENTATION FEBRUARY 11, 2025 NYSE AMERICAN: ELMD INNOVATION LEADER IN AIRWAY CLEARANCE TECHNOLOGIES Exhibit 99.2 | 1 Investor Presentation Electromed, Inc. Investor Presentation February 11, 2025 NYSE American: ELMD Innovation Leader in Airway Clearance Technologies | 2 Investor Presentation Forward Looking Statements Certain statements in this press release constitute forward - looking statements as defi…
Read attachment ↗